Pharmacokinetic profiling of two novel antiviral coronavirus protease inhibitors towards clinical application for COVID-19 and beyond.

Therapeutic Innovation Australia 2026 Open access

Read full text

Authors: Therapeutic Innovation Australia

DOI: 10.82292/k8zs-8q56

Cited by: 0

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Pharmacogenetics and Drug Metabolism